HIV/AIDSTWCNCT03897049
Evaluation of the Trans Women Connected Mobile App for Changes in Sexual Health-related Behavior Among Transgender Women
A study testing Trans Women Connected and General Health App in people with HIV/AIDS and Health Knowledge, Attitudes, Practice, run by ETR Associates at 1 site in United States.
Trial summary
The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month… Read more about this study
- Who is it for?
- Ages 18 to 49 yearsHealthy volunteers can take part
- Conditions the study is for
- HIV/AIDS, Health Knowledge, Attitudes, Practice, STI
- What is being tested?
- Trans Women Connected and General Health App
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 574 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Apr 2021to 7 Sep 2022
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 49 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- aged 18-49 at the start of the study.
- self-identify as transgender women
- self-identify as sexually active with more than one partner in the prior 90 days
- at least one sexual partner in the last 90 days had a penis
- has a smartphone
- resides in the U.S.
Who cannot join
- Anyone not meeting inclusion criteria
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Randomized Controlled Trial of Trans Women Connected: a Mobile App Delivered Sexual Health Promotion Program
The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. The baseline and follow-up assessments will collect data on demographic characteristics, measures related to our primary and secondary outcomes, and psychosocial measures. The primary outcome measures are self-reported sexually transmitted infection (STI)/HIV testing and sex without a condom, with secondary measures including sexual risk behaviors, health care visits, perceived social support/connectedness, pre-exposure prophylaxis (PrEP) use, self-efficacy in negotiation/communication, and comfort with gender identity and appearance. In addition, process data, such as forum content, and usage data will be collected and analyzed.
Read the detailed description
A 2-arm cluster randomized controlled trial will be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. The Trans Women Connected intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths-based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP content, post-exposure prophylaxis (PEP) content, and communication forums.
To be eligible, participants will be required to self-identify as transgender women; report having had 2 or more sexual partners in the past 90 days with at least one of those partners having a penis; be age 18-49 at baseline; own a smartphone; and reside in any state in the United States. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline.
Participants will be recruited using a variety of methods, including: 1) Regional transwomen recruitment/retention specialists who are responsible for facilitating recruitment in their regions, addressing study questions, and maintaining connections with each participant to support study engagement; 2) Organizations. Organizations from across the U.S., at least one per state, that serve transgender women will be approached to help recruit participants through social media and in-person. 3) Google Adwords. Placing study advertisements on Google based on keyword for participant recruitment has been shown to be effective. 4) Social Media Advertising including targeted advertising on social media sites (Facebook/Instagram) and sponsoring study posts with social media influencers in the Transwomen community. Social media advertising has been shown to be favorable in terms of its cost-effectiveness, usability, and reach, especially with hard-to-reach populations, young adults and lesbian, gay, bisexual, and transgender (LGBT) populations. 5) Participant Recruitment (participants sharing information about the study within their networks). Participants will complete 4 web-based surveys and will receive $20 for baseline survey, $20 for an immediate posttest, $40 at 3-month follow up, $60 at final 6-month follow up.
Randomization. The 2-arm randomized controlled trial involves randomizing individual participants using an equal allocation (allocation ratio 1:1) to receive the full TWC app or an attention control app. Participants were randomized after completing their baseline surveys using the randomizer feature of Qualtrics.
Data Collection. Participants will be surveyed at 4 time points. 1) before randomization, 2) after using the mobile app for 1 month, 3) three months after completion of the baseline, and 4) six months after completion of the baseline. Surveys will be completed online through emailed or texted links. Data will also be collected through the apps. This includes usage data, such as what activities participants used and for how long, and process data, which includes content on the communication forum, text answers in the app, and visual content such as vision boards. Participants will receive an incentive of $20 for the baseline and immediate post-intervention survey, $40 for the 3-month follow up survey, and $60 for the 6 month follow up survey.
Study Hypotheses. Primary Hypotheses 1 (representing sexual health risk reduction through engagement in care 1) Women in the intervention group will report more STI testing (higher rates of STI testing in the prior 90 days) than the comparison group. Primary Hypotheses 2, women in the intervention group will report fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse. Secondary Hypotheses (representing other important sexual health risk, and psychosocial outcomes):1) Participants in the intervention group will report reduced sexual risk taking including fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse; greater use of condom use at last intercourse (receptive anal or vaginal); and increased use of PrEP for those that are HIV- 2) Participants in the intervention group will engage more with proactive health care and report more health care visits. 3) Participants in the treatment group will report more connectedness with other transgender women, including perceived social support and engagement with a mentor. 4) Participants in the intervention group will report greater efficacy in having safer sex and in communication both with partners and health care workers. 5) Those in the treatment group will have greater acceptance of their gender identity/comfort with gender identity.
- Conditions
- HIV/AIDS, Health Knowledge, Attitudes, Practice, STI
- Being tested
- Trans Women Connected, General Health App
- Keywords
- Transgender Women, STI, Sexual Health, HIV/AIDS
- Medical subject headings
- Acquired Immunodeficiency Syndrome, Behavior, Sexually Transmitted Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Trans Women ConnectedBehavioural
The intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP/PEP content, and communication forums.
General Health AppBehavioural
The control group will download a mobile app that addresses COVID and provides COVID resources.
| Study group | Role | What they receive |
|---|---|---|
| TWC App | Experimental | The intervention is a mobile app delivered sexual health promotion program designed specifically for transgender women. The mobile app includes 42 interactive activities plus resource maps, opportunities for mentoring, and communication forums for connecting with other transgender women. Receives: Behavioral: Trans Women Connected |
| General Health App | Active comparator | An alternate mobile app (TWC COVID only) designed specifically for transgender women. The mobile app includes 7 interactive activities focused on COVID and COVID resources. Receives: Behavioral: General Health App |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-reported HIV or STI Testing in Past 3 Months
Participant reported having tested for HIV or STI in the past 3 months
Measured: 3-months post intervention
Self-reported HIV or STI Testing in Past 3 Months
Participant reported having tested for HIV or STI in the past 3 months
Measured: 6-months post intervention
Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months
Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months
Measured: 3-months post intervention
Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months
Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months
Measured: 6-months post intervention
Secondary outcomes (22)
Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse
Participant reported using a condom at last receptive anal intercourse or vaginal intercourse
Measured: 3-month post intervention
Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse
Participant reported using a condom at last receptive anal intercourse or vaginal intercourse
Measured: 6-month post intervention
Health Care Visits in Past 3 Months
Average # of self-reported visits to a health care provider (of any type and by type)
Measured: 3-months post intervention
Health Care Visits in Past 3 Months
Average # of self-reported visits to a health care provider (of any type and by type)
Measured: 6-months post intervention
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)
Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.
Measured: 1-month post intervention
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)
Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.
Measured: 3-month post intervention
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)
Perceptions of social support, mean score of 8 items measured on a five point scale (1-5). Scale range is from 1 - 5 with a higher number indicating greater perceived social support, which is a better outcome.
Measured: 6-month post intervention
Engaged as/With Mentor in Past 3 Months
Self-reported number of contacts in the past 3 months as a mentor/mentee for guidance or support
Measured: 3-months post intervention
Engaged as/With Mentor in Past 3 Months
Self-reported number of contacts, in the past 3 months, as a mentor/mentee for guidance or support
Measured: 6-months post intervention
PrEP Uptake
Self-reported uptake of PrEP among HIV since last measurement period- subsample
Measured: 1-month post intervention
PrEP Uptake
Self-reported uptake of PrEP among HIV since last measurement period- subsample
Measured: 3-month post intervention
PrEP Uptake
Self-reported uptake of PrEP among HIV since last measurement period- subsample
Measured: 6-month post intervention
Condom/Barrier Negotiation Self Efficacy Scale
Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy
Measured: 1 month post-intervention
Condom/Barrier Negotiation Self Efficacy Scale
Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy
Measured: 3- month post intervention
Condom/Barrier Negotiation Self Efficacy Scale
Scale measures self-efficacy in decisions around using protective barriers during sex. Average of 8 items on a 7-point scale (1 to 7), with a range of 1 - 7, with a higher score indicating better outcomes, or greater self-efficacy
Measured: 6-month post intervention
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale
Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services
Measured: 1-month post intervention
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale
Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services
Measured: 3-month post intervention
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale
Sub-scale measures comfort navigating health services. Average of 5 items on a 4-point scale (1-4), with a range of 1 - 4, with a higher score indicating greater comfort navigating health services
Measured: 6- month post intervention
Transgender Congruence Scale (TCS)
Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity
Measured: 1-month post intervention
Transgender Congruence Scale (TCS)
Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity
Measured: 3-month post intervention
Transgender Congruence Scale (TCS)
Scale measures degree of comfort with external appearance as it relates to gender identity. Average of 12 items on a 5-point scale, with a range of 1 - 5, with a higher score indicating a perception that their appearance reflects their chosen gender identity
Measured: 6-month post intervention
Trans Women Connected Satisfaction Survey
Scale measures participants' reactions to the app. Average of 3 items on a 5-point scale with a range of 1 to 5 with a higher score indicating greater levels of satisfaction with the app.
Measured: 1-month post intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Apr 2019
- Study start1 Apr 2021
- Primary completion7 Sep 2022
- Study completion7 Sep 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for HIV/AIDSStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is a two arm randomized controlled trial. Implementation. After randomization, participants will be granted access to download and install their respective Trans Women Connected mobile apps (intervention or attention control).
- Masking
- None (open label)
- Enrolment
- 574 participants (actual)
Sponsor and investigators
- Lead sponsor
- ETR Associates
- Sponsor type
- University, hospital or other
- Collaborators
- dfusion Inc, Portland State University, National Institute on Minority Health and Health Disparities (NIMHD)
- Responsible party
- Sponsor
- Investigators
- Tamara Kuhn, Principal investigator, dfusion Inc
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03897049
- Sponsor's protocol ID
- TransWomenConnected
- Other IDs
- 5R44MD012279
- Acronym
- TWC
- Status last verified
- Dec 2023
- First submitted
- 25 Mar 2019
- Last updated
- 6 May 2024
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005 Dec;9(4):387-402. doi: 10.1007/s10461-005-9012-3.
PubMed 16235135
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Trial of Trans Women Connected: a Mobile App Delivered Sexual Health Promotion Program
- ClinicalTrials.gov ID
- NCT03897049
- Acronym / sponsor ID
- TWC / TransWomenConnected
- Conditions
- HIV/AIDS, Health Knowledge, Attitudes, Practice, STI
- Keywords
- Transgender Women, STI, Sexual Health, HIV/AIDS
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 574 participants (actual)
- Lead sponsor
- ETR AssociatesUniversity, hospital or other
- Collaborators
- dfusion Inc, Portland State University, National Institute on Minority Health and Health Disparities (NIMHD)
- Study start
- 1 Apr 2021 (actual)
- Primary completion
- 7 Sep 2022 (actual)
- Study completion
- 7 Sep 2022 (actual)
- First posted
- 1 Apr 2019 (actual)
- Results
- Posted 6 May 2024
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. The baseline and follow-up assessments will collect data on demographic characteristics, measures related to our primary and secondary outcomes, and psychosocial measures. The primary outcome measures are self-reported sexually transmitted infection (STI)/HIV testing and sex without a condom, with secondary measures including sexual risk behaviors, health care visits, perceived social support/connectedness, pre-exposure prophylaxis (PrEP) use, self-efficacy in negotiation/communication, and comfort with gender identity and appearance. In addition, process data, such as forum content, and usage data will be collected and analyzed.
Detailed description
A 2-arm cluster randomized controlled trial will be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. The Trans Women Connected intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths-based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP content, post-exposure prophylaxis (PEP) content, and communication forums.
To be eligible, participants will be required to self-identify as transgender women; report having had 2 or more sexual partners in the past 90 days with at least one of those partners having a penis; be age 18-49 at baseline; own a smartphone; and reside in any state in the United States. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline.
Participants will be recruited using a variety of methods, including: 1) Regional transwomen recruitment/retention specialists who are responsible for facilitating recruitment in their regions, addressing study questions, and maintaining connections with each participant to support study engagement; 2) Organizations. Organizations from across the U.S., at least one per state, that serve transgender women will be approached to help recruit participants through social media and in-person. 3) Google Adwords. Placing study advertisements on Google based on keyword for participant recruitment has been shown to be effective. 4) Social Media Advertising including targeted advertising on social media sites (Facebook/Instagram) and sponsoring study posts with social media influencers in the Transwomen community. Social media advertising has been shown to be favorable in terms of its cost-effectiveness, usability, and reach, especially with hard-to-reach populations, young adults and lesbian, gay, bisexual, and transgender (LGBT) populations. 5) Participant Recruitment (participants sharing information about the study within their networks). Participants will complete 4 web-based surveys and will receive $20 for baseline survey, $20 for an immediate posttest, $40 at 3-month follow up, $60 at final 6-month follow up.
Randomization. The 2-arm randomized controlled trial involves randomizing individual participants using an equal allocation (allocation ratio 1:1) to receive the full TWC app or an attention control app. Participants were randomized after completing their baseline surveys using the randomizer feature of Qualtrics.
Data Collection. Participants will be surveyed at 4 time points. 1) before randomization, 2) after using the mobile app for 1 month, 3) three months after completion of the baseline, and 4) six months after completion of the baseline. Surveys will be completed online through emailed or texted links. Data will also be collected through the apps. This includes usage data, such as what activities participants used and for how long, and process data, which includes content on the communication forum, text answers in the app, and visual content such as vision boards. Participants will receive an incentive of $20 for the baseline and immediate post-intervention survey, $40 for the 3-month follow up survey, and $60 for the 6 month follow up survey.
Study Hypotheses. Primary Hypotheses 1 (representing sexual health risk reduction through engagement in care 1) Women in the intervention group will report more STI testing (higher rates of STI testing in the prior 90 days) than the comparison group. Primary Hypotheses 2, women in the intervention group will report fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse. Secondary Hypotheses (representing other important sexual health risk, and psychosocial outcomes):1) Participants in the intervention group will report reduced sexual risk taking including fewer acts of receptive condomless anal intercourse or condomless vaginal intercourse; greater use of condom use at last intercourse (receptive anal or vaginal); and increased use of PrEP for those that are HIV- 2) Participants in the intervention group will engage more with proactive health care and report more health care visits. 3) Participants in the treatment group will report more connectedness with other transgender women, including perceived social support and engagement with a mentor. 4) Participants in the intervention group will report greater efficacy in having safer sex and in communication both with partners and health care workers. 5) Those in the treatment group will have greater acceptance of their gender identity/comfort with gender identity.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- This is a two arm randomized controlled trial. Implementation. After randomization, participants will be granted access to download and install their respective Trans Women Connected mobile apps (intervention or attention control).
| Arm | Type | Receives |
|---|---|---|
| TWC App | Experimental | Behavioral: Trans Women ConnectedThe intervention is a mobile app delivered sexual health promotion program designed specifically for transgender women. The mobile app includes 42 interactive activities plus resource maps, opportunities for mentoring, and communication forums for connecting with other transgender women. |
| General Health App | Active comparator | Behavioral: General Health AppAn alternate mobile app (TWC COVID only) designed specifically for transgender women. The mobile app includes 7 interactive activities focused on COVID and COVID resources. |
Who may qualify
- Ages
- 18 to 49 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- aged 18-49 at the start of the study.
- self-identify as transgender women
- self-identify as sexually active with more than one partner in the prior 90 days
- at least one sexual partner in the last 90 days had a penis
- has a smartphone
Key exclusion criteria (1 listed)
- Anyone not meeting inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Trans Women ConnectedThe intervention will address the unique needs of transgender women and the lack of evidence-based, transgender-specific HIV prevention. It is a mobile app delivered sexual health promotion program that engages transgender women through a strengths based approach to HIV prevention and sexual health that uses the power of social networks to identify and encourage protective factors that support the health of transgender women. This approach recognizes the social and structural barriers that transgender women face. In the context of these barriers, which include stigma and discrimination in a number of interconnected spheres, individually-focused behavioral interventions are insufficient. This intervention takes a more comprehensive approach that intentionally targets community strengths and challenges. The mobile app will include more than 30 interactive activities including resource maps, PrEP/PEP content, and communication forums. | Behavioural | TWC App |
| General Health AppThe control group will download a mobile app that addresses COVID and provides COVID resources. | Behavioural | General Health App |
Primary outcome
Self-reported HIV or STI Testing in Past 3 Months
Time frame: 3-months post intervention
Participant reported having tested for HIV or STI in the past 3 months
Self-reported HIV or STI Testing in Past 3 Months
Time frame: 6-months post intervention
Participant reported having tested for HIV or STI in the past 3 months
Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months
Time frame: 3-months post intervention
Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months
Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months
Time frame: 6-months post intervention
Participant reported having had receptive anal intercourse without a condom or receptive vaginal intercourse without a condom in the past 3 months
22 secondary outcomes
Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse
Time frame: 3-month post intervention
Use of a Condom at Last Receptive Anal Intercourse or Vaginal Intercourse
Time frame: 6-month post intervention
Health Care Visits in Past 3 Months
Time frame: 3-months post intervention
Health Care Visits in Past 3 Months
Time frame: 6-months post intervention
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)
Time frame: 1-month post intervention
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)
Time frame: 3-month post intervention
Mini-Medical Outcomes Study--Social Support Survey (mMOS-SS)
Time frame: 6-month post intervention
Engaged as/With Mentor in Past 3 Months
Time frame: 3-months post intervention
Engaged as/With Mentor in Past 3 Months
Time frame: 6-months post intervention
PrEP Uptake
Time frame: 1-month post intervention
PrEP Uptake
Time frame: 3-month post intervention
PrEP Uptake
Time frame: 6-month post intervention
Condom/Barrier Negotiation Self Efficacy Scale
Time frame: 1 month post-intervention
Condom/Barrier Negotiation Self Efficacy Scale
Time frame: 3- month post intervention
Condom/Barrier Negotiation Self Efficacy Scale
Time frame: 6-month post intervention
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale
Time frame: 1-month post intervention
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale
Time frame: 3-month post intervention
Health Education Impact Questionnaire (heiQ) Health Services Navigation Sub-Scale
Time frame: 6- month post intervention
Transgender Congruence Scale (TCS)
Time frame: 1-month post intervention
Transgender Congruence Scale (TCS)
Time frame: 3-month post intervention
Transgender Congruence Scale (TCS)
Time frame: 6-month post intervention
Trans Women Connected Satisfaction Survey
Time frame: 1-month post intervention
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2024.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Background: PubMed 16235135Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005 Dec;9(4):387-402. doi: 10.1007/s10461-005-9012-3.
- Individual participant dataSharing planned: No
Related trials for HIV/AIDS
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Not yet recruiting
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Recruiting
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
HIV, HIV Treatment
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tamara Kuhn principal investigator
dfusion Inc
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Trans Women Connected and General Health App in people with HIV/AIDS and Health Knowledge, Attitudes, Practice, run by ETR Associates at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 6 May 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-reported HIV or STI Testing in Past 3 Months (time frame: 3-months post intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03897049, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2024.